ALIGNED GENETICS, INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4,465 KRW | -0.45% |
|
-1.00% | +10.79% |
| 2016 | Logos Biosystems, Inc. has completed an IPO in the amount of KRW 18.056448 billion. | CI |
| 2016 | Logos Biosystems, Inc. has filed an IPO. | CI |
| Sales 2022 | 13.75B 10.07M 13.75M | Sales 2023 | 15.21B 11.14M 15.21M | Capitalization | 57.95B 42.42M 57.95M |
|---|---|---|---|---|---|
| Net income 2022 | 2.33B 1.71M 2.33M | Net income 2023 | 3.24B 2.37M 3.24M | EV / Sales 2022 | 3.26 x |
| Net cash position 2022 | 9.32B 6.82M 9.32M | Net cash position 2023 | 10.26B 7.51M 10.26M | EV / Sales 2023 | 3.13 x |
| P/E ratio 2022 |
23.2
x | P/E ratio 2023 |
17.9
x | Employees | - |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 60.09% |
More Fundamentals
* Assessed data
| 1 day | -0.45% | ||
| 1 week | -1.00% | ||
| Current month | -1.33% | ||
| 1 month | -1.33% | ||
| 3 months | +5.43% | ||
| 6 months | +25.42% | ||
| Current year | +10.79% |
1 week
4 415.00
4 565.00
1 month
4 255.004 575.00
Current year
3 950.004 640.00
1 year
3 460.006 175.00
3 years
3 450.006 925.00
5 years
2 002.509 150.00
10 years
2 002.509 150.00
| Managers | Title | Age | Since |
|---|---|---|---|
Neon C. Jung
PSD | President | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Byong Seung Cho
BRD | Director/Board Member | - | - |
Kim Hee-Jeong
BRD | Director/Board Member | - | - |
Nu-Li Jeon
BRD | Director/Board Member | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-02 | 4,460 | -0.11% | 81,850 |
| 24-04-30 | 4,465 | -0.45% | 28,137 |
| 24-04-29 | 4,485 | +0.22% | 126,321 |
| 24-04-26 | 4,475 | -0.33% | 156,040 |
| 24-04-25 | 4,490 | -0.22% | 42,625 |
End-of-day quote Korea S.E., April 29, 2024
More quotes
Aligned Genetics Inc, formerly Logos Biosystems Inc, is a Korea-based company engaged in the manufacture and sale of medical equipment. The Company's products mainly consist of automated cell counters, such as LUNA, LUNA-FL, LUNA-STEM, LUNA-II, LUNA- YF, QUANTOM, tissue clearing systems, such as X-CLARITY, and digital cell imaging systems, such as iRiS.
Calendar
2024-05-12
- Q1 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| +10.79% | 46.4M | |
| -15.52% | 18.54B | |
| +17.00% | 1.85B | |
| -0.51% | 1.66B | |
| +25.21% | 1.23B | |
| -13.90% | 989M | |
| -21.76% | 896M | |
| -5.01% | 744M | |
| -19.85% | 673M | |
| +7.31% | 490M |
- Stock Market
- Equities
- A238120 Stock
